Literature DB >> 30901771

Progressive Characterization of Visual Phenotype in Bardet-Biedl Syndrome Mutant Mice.

Viola Kretschmer1, Sarita Rani Patnaik1, Friedrich Kretschmer2, Mira Manilal Chawda3, Victor Hernandez-Hernandez3,4, Helen Louise May-Simera1.   

Abstract

Purpose: Bardet-Biedl syndrome (BBS) is an archetypical ciliopathy caused by defective ciliary trafficking and consequent function. Insights gained from BBS mouse models are applicable to other syndromic and nonsyndromic retinal diseases. This progressive characterization of the visual phenotype in three BBS mouse models sets a baseline for testing therapeutic interventions.
Methods: Longitudinal acquisition of electroretinograms, optical coherence tomography scans, and visual acuity using the optomotor reflex in Bbs6/Mkks, Bbs8/Ttc8, and Bbs5 knockout mice. Gene and protein expression analysis in vivo and in vitro.
Results: Complete loss of BBS5, BBS6, or BBS8 leads to different rates of retinal degeneration and visual function over time. BBS8-deficient mice showed the fastest rate of degeneration, and BBS8 seems to be required for cone photoreceptors to reach functional maturity. In contrast, the loss of BBS5 (a further BBSome component) showed very little degeneration. Loss of BBS8 versus BBS5 resulted in different physiologic responses both in vivo and in vitro. BBS6-deficient mice show a slower rate of degeneration with both rod and cone function reducing at a similar rate. Conclusions: The mouse models analyzed show distinct and diverging courses of degeneration upon loss of BBS5, BBS6, or BBS8, which can be used as a benchmark to test therapeutic interventions. Close consideration of the different phenotypes reveal subtle but important differences relating to their function. Because we also see differences in terms of phenotype depending on the type of visual assessment used, our data highlight the importance of using a combinatorial approach for assessment of visual function.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30901771     DOI: 10.1167/iovs.18-25210

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Photoreceptor cilia, in contrast to primary cilia, grant entry to a partially assembled BBSome.

Authors:  Ying Hsu; Seongjin Seo; Val C Sheffield
Journal:  Hum Mol Genet       Date:  2021-03-25       Impact factor: 6.150

2.  A mouse model of BBS identifies developmental and homeostatic effects of BBS5 mutation and identifies novel pituitary abnormalities.

Authors:  Melissa R Bentley-Ford; Staci E Engle; Kelsey R Clearman; Courtney J Haycraft; Reagan S Andersen; Mandy J Croyle; Addison B Rains; Nicolas F Berbari; Bradley K Yoder
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

3.  Bardet-Biedl syndrome-7 (BBS7) shows treatment potential and a cone-rod dystrophy phenotype that recapitulates the non-human primate model.

Authors:  Tomas S Aleman; Erin C O'Neil; Keli O'Connor; Yu You Jiang; Isabella A Aleman; Jean Bennett; Jessica I W Morgan; Brian W Toussaint
Journal:  Ophthalmic Genet       Date:  2021-03-17       Impact factor: 1.274

4.  BBSome Component BBS5 Is Required for Cone Photoreceptor Protein Trafficking and Outer Segment Maintenance.

Authors:  Katie L Bales; Melissa R Bentley; Mandy J Croyle; Robert A Kesterson; Bradley K Yoder; Alecia K Gross
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

5.  Comparative Natural History of Visual Function From Patients With Biallelic Variants in BBS1 and BBS10.

Authors:  Monika K Grudzinska Pechhacker; Samuel G Jacobson; Arlene V Drack; Matteo Di Scipio; Ine Strubbe; Wanda Pfeifer; Jacque L Duncan; Helene Dollfus; Nathalie Goetz; Jean Muller; Andrea L Vincent; Tomas S Aleman; Anupreet Tumber; Caroline Van Cauwenbergh; Elfride De Baere; Emma Bedoukian; Bart P Leroy; Jason T Maynes; Francis L Munier; Erika Tavares; Eman Saleh; Ajoy Vincent; Elise Heon
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.